Literature DB >> 22173431

Biosimilars: Is absence of proof of difference, proof of absence of difference?

M Dicato.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22173431     DOI： 10.1007/s11523-011-0186-5

Source DB:  PubMed          Journal:  Target Oncol        ISSN： 1776-2596            Impact factor:   4.493


× No keyword cloud information.
  1 in total

Review 1.  Is the decision on the use of biosimilar growth hormone based on high quality scientific evidence? - a systematic review.

Authors:  Linda Fryklund; Martin Ritzén; Göran Bertilsson; Marianne Heibert Arnlind
Journal:  Eur J Clin Pharmacol       Date:  2014-02-26       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.